Generics 21

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Enzalutamide manufacturers

21 products found

Filters

21 products found

enzalutamide

Tablets 40 mg, 80 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP
Comments
Western EU SPC Expiry: 21 Jun 2028 DCP: Q2 2024
Manufacturer #276

Manufacturer usually replies in 1 days

enzalutamide

Tablets 160 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Dossier availability date: Q3 2025 Western EU SPC Expiry: 21 Jun 2028
Manufacturer #276

Manufacturer usually replies in 1 days

enzalutamide

Tablets, film coated 40 mg, 80 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Colombia , Costa Rica , Dominican Republic , Guatemala
Comments
Ref: Xtandi®
Manufacturer #252

Manufacturer usually replies in 2 days

enzalutamide

Tablets 40 mg, 80 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP
Comments
Western EU SPC Expiry: 21 Jun 2028 DCP: Q2 2024
Manufacturer #276

Manufacturer usually replies in 1 days

enzalutamide

Capsules 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #21467

Manufacturer usually replies in 9 days

enzalutamide

Tablets, film coated 40 mg, 80 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Dossier availability date: Q4 2024
Manufacturer #21467

Manufacturer usually replies in 9 days

enzalutamide

Tablets, film coated 40 mg, 80 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Dossier availability date: Q2 2026
Manufacturer #519

Manufacturer usually replies in 6 days

enzalutamide

Tablets, film coated 40 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
Iceland
GMP approvals
EU GMP
Manufacturer #28915

Manufacturer usually replies in 14 days

enzalutamide

Tablets, film coated 40 mg, 80 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Comments
Dossier availability date: Q3 2025
Manufacturer #437
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 11 days

enzalutamide

Tablets, film coated 40 mg, 80 mg

Dossier type
US CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP
Comments
Indication: Prostatic Neoplasm; Dossier Status: Under development. Dossier is expected to be ready Q4 2025 (EU), Q1 2026 (US).
Manufacturer #385

A pharmaceutical manufacturer based in the EU that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, Africa, and Asia for 60+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 11 days

enzalutamide

Oral solution 40 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #31060

Manufacturer usually replies in nan days

enzalutamide

Tablets 40 mg, 80 mg , 160 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Chile , Panama
Available for
Licensing with supply
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 6 days

enzalutamide

Capsules 40 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Iraq
Manufacturer #656
It is a fully integrated developer, manufacturer, and marketer of a wide range of soft gelatin formulations, with a strong regulatory and infrastructure back end to support its research and development and global market expansion strategy. The company began licensing and distributing professionally evaluated components and formulations in the OTC and Nutraceutical categories in 2016.

Manufacturer usually replies in 8 days

enzalutamide

Capsules 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #22283

Manufacturer usually replies in 4 days

enzalutamide

Capsules 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #19588

Manufacturer usually replies in 7 days

enzalutamide

Capsules 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #30013

Manufacturer usually replies in 2 days

enzalutamide

Capsules 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17417

Manufacturer usually replies in 6 days

enzalutamide

Capsules 40 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
WHO
Manufacturer #31073

Manufacturer usually replies in 6 days

enzalutamide

Capsules 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS, AR
Manufacturer #15733
One of the leading manufacturers in cosmetic and medicinal products in the South American Continent. The company has been committed since 1990-is to developing and manufacturing high-quality products that allow healing and improve someone’s life. They are a major exporter of its therapies to different regions such as Latin America and Asia. Medicine is manufactured for pain, gastroenterology, hepatology, and cardiology.

Manufacturer usually replies in 17 days

enzalutamide

Capsules 40 mg, 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #30830

Want to view all 21 products? Create your free account today!

ENZALUTAMIDE manufacturer

Enzalutamide belongs to a group of medications known as androgen receptor inhibitors. Enzalutamide, an antiandrogen, acts as an antagonist to the androgen receptor. This is the biological target of androgens such as testosterone and dihydrotestosterone. It blocks the actions of androgen, which stops the spread and growth of cancer cells. Enzalutamide (brand name Xtandi) is a nonsteroidal antiandrogen medication that is used to treat prostate cancer. Enzalutamide is a selective, silent antagonist of the androgen receiver (AR), which is the biological target for androgens such as testosterone and dihydrotestosterone. Because it is more effective as an antiandrogen than NSAAs of the "first generation", such a drug can be called a "second-generation" NSAA. DHT, which is the endogenous ligand for the AR in the prostate gland, has a 2-fold lower affinity than the drug. However, Enzalutamide is not the perfect drug to fight cancer. It is only effective for a limited time and then the growth of the disease is not affected. Research is ongoing to determine the mechanisms that could lead to Enzalutamide resistance. Enzalutamide does have some side effects as well when it's added to castration, may cause back pain, diarrhea, and hot flashes. Rarely, it can cause seizures. There is a high chance of drug interactions. If you experience any serious side effects from Enzalutamide, such as severe low back pain, difficulty walking or standing, pain or weakness lower body, sudden loss of bladder control or bowel control or fever, yellow or green mucus production, stabbing chest pains, or severe nausea, consult your doctor immediately. Warnings: Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking ENZALUTAMIDE: You should not use This medical drug if you are allergic to it This drug may also be used for purposes that may not have been listed in this medication guide. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified rosiglitazone manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

How does ENZALUTAMIDE work?

The usage of this pharmaceutical substance: Read the Guide and, if available, the Patient Information Leaflet that will be provided by your pharmacist before you start taking ENZALUTAMIDE. If you have any questions related to this medical remedy, ask your pharmacist or doctor. This pharmaceutical product comes as a capsule or a tablet to take by mouth. It is normally taken without or with food once a day. Take this medical remedy at around the same time every day. Follow the instructions on your prescription label carefully, and ask your doctor or pharmacist to clarify any part that you may not understand. Take this remedy exactly as directed. Do not take less or more of it or take it more often than directed by your health care professional. Swallow the capsules or tablets whole; do not divide, crush, chew, dissolve, or open them. Your instructor may tell you to stop taking this drug for a short time or decrease your dosage if you encounter severe side effects during your procedure. Be sure to talk to your pharmacist or your doctor about how you are feeling during your treatment.

The Wholesale Price of ENZALUTAMIDE?

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the price. The price of Xtandi oral capsule 40 mg is around $12,825 for a supply of 120 capsules, depending on the pharmacy you visit. Enzalutamide is sold under the brand name Xtandi, among others such as Pfizer Oncology, Pfizer, and Astellas.

Sourcing the ENZALUTAMIDE Manufacturers and Suppliers

If you are looking to find ENZALUTAMIDE manufacturers and ENZALUTAMIDE suppliers, locate them quickly using Pipelinepharma's online marketplace. With this convenient B2B platform, you can order types of medications and quantities you require from companies that have passed our stringent vetting and quality control procedures. Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of ENZALUTAMIDE offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and these substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of ENZALUTAMIDE. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where ENZALUTAMIDE is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen ENZALUTAMIDE manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.